Aandelen in “Medische/verpleegkundige diensten”

Aandeel Datum Koers Evolutie
vlag DaVita Inc 27/03 154,430 USD
-1,49% 		-1,49%

Nieuws over “Medische/verpleegkundige diensten”

27/03 · Castle Biosciences' DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026 · Persbericht

27/03 · Castle Biosciences' DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026 · Persbericht

24/03 · Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data · Persbericht

18/03 · DaVita Highlights Continued Progress in Value-Based Kidney Care as CKCC Results Show Year-Over-Year Improvement · Persbericht

16/03 · Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor · Persbericht

12/03 · MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 · Persbericht

5/03 · Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion · Persbericht

2/03 · RadNet Acquires Gleamer, Making RadNet’s DeepHealth the Largest Provider of Radiology Clinical AI Solutions Worldwide · Persbericht

25/02 · RAMSAY SANTE : Half-year results at the end of December 2025 · Persbericht

24/02 · DaVita Inc. to Participate in TD Cowen's 46th Annual Health Care Conference · Persbericht

24/02 · Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band · Persbericht

20/02 · RAMSAY SANTE : New step for Ramsay Santé in connection with Ramsay Health Care's proposal to distribute its shareholding in Ramsay Santé to its shareholders · Persbericht

12/02 · Guardant Health Launches Community Colorectal Cancer Screening Grant Program in Recognition of CRC Awareness Month, Applications Now Open · Persbericht

2/02 · DaVita Inc. 4th Quarter 2025 Results · Persbericht

21/01 · DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call · Persbericht

9/01 · Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned · Persbericht

Mijn selecties